tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PTC Therapeutics price target lowered to $76 from $82 at BofA
PremiumThe FlyPTC Therapeutics price target lowered to $76 from $82 at BofA
18d ago
PTC Therapeutics price target lowered to $73 from $79 at Wells Fargo
Premium
The Fly
PTC Therapeutics price target lowered to $73 from $79 at Wells Fargo
18d ago
PTC Therapeutics price target lowered to $63 from $64 at Jefferies
Premium
The Fly
PTC Therapeutics price target lowered to $63 from $64 at Jefferies
18d ago
PTC Therapeutics: Hold Rating Amid Regulatory Setbacks and Sephience Growth Potential
PremiumRatingsPTC Therapeutics: Hold Rating Amid Regulatory Setbacks and Sephience Growth Potential
18d ago
PTC Therapeutics Receives FDA Complete Response Letter
Premium
Company Announcements
PTC Therapeutics Receives FDA Complete Response Letter
18d ago
PTC Therapeutics receives Complete Response Letter for vatiquinone NDA
Premium
The Fly
PTC Therapeutics receives Complete Response Letter for vatiquinone NDA
18d ago
PTC Therapeutics price target raised to $79 from $78 at Wells Fargo
PremiumThe FlyPTC Therapeutics price target raised to $79 from $78 at Wells Fargo
30d ago
PTC Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
PTC Therapeutics Reports Q2 2025 Financial Results
30d ago
PTC Therapeutics: Balancing Optimism and Uncertainty Amidst New Product Launches and Regulatory Decisions
Premium
Ratings
PTC Therapeutics: Balancing Optimism and Uncertainty Amidst New Product Launches and Regulatory Decisions
30d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100